Savannah Neal, | |
1125 Union St Apt 4, Emporia, KS 66801-3035 | |
(864) 337-7858 | |
Not Available |
Full Name | Savannah Neal |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Sports Medicine |
Location | 1125 Union St Apt 4, Emporia, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578231627 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083S0010X | Preventive Medicine - Sports Medicine | 2000050241 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Savannah Neal, 1 Kellogg Cir, Emporia, KS 66801-5415 Ph: (620) 341-1200 | Savannah Neal, 1125 Union St Apt 4, Emporia, KS 66801-3035 Ph: (864) 337-7858 |
News Archive
Slimmer Silhouette is excited to announce the Perfect 10 Challenge, an engaging health and life-makeover challenge for 2010 that encourages women in leadership positions at charities and non-profit organizations nationwide to champion their cause by taking better care of themselves.
According to Australian researchers the pollution caused by heavy traffic affects the size of an unborn baby.
Researchers at the University of Alabama at Birmingham (UAB) have found that nutrients in red wine may help reduce the risk of developing prostate cancer. The study involved male mice that were fed a plant compound found in red wine called resveratrol, which has shown anti-oxidant and anti-cancer properties.
The meningococcal vaccine MenAfriVac, which is made by the Indian generic drug company Serum Institute, is "dramatically better" at producing a protective effect among African children in three countries than "older so-called meningococcal polysaccaride vaccines, including Mencevax from GlaxoSmithKline," according to a paper describing two studies published in the New England Journal of Medicine, Reuters reports.
A new study, recently released as a preprint on the medRxiv* server, reports the intriguing finding that the cross-neutralizing antibodies elicited by human seasonal coronaviruses (sCoVs) show varying ability to prevent binding between the SARS-CoV-2 spike antigen and its cognate receptor, the angiotensin-converting enzyme 2 (ACE2).
› Verified 7 days ago